Tag archive: FDA

The European Union announced this week that it will ban the use of X-ray body scanners in airports across the EU due to “health and safety” concerns. The same security scanners, which are used to find firearms and explosives hidden on passengers' bodies, will still be used at airports in the US. A ProPublica/PBS NewsHour report from earlier this month exposed the health risks associated with the use of these types of security… Read More

At a news conference this morning in Rhode Island, U.S. attorney Peter F. Neronha announced that Google has agreed to pay $500 million for improperly enabling Canadian pharmacies to use Google advertising services to target U.S. consumers with discount drug offers. According to Neronha, the settlement is the largest of its kind in U.S. history—and the figure stems partly from Google parting with revenue it earned from Canadian pharmacies… Read More

The U.S. Food and Drug Administration (FDA) is meeting with pharmaceutical representatives in Washington, D.C. to discuss how it should handle online drug ads shown on the Internet.

As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites. The Food and Drug Administration will convene a two-day meeting beginning Thursday to hear the drug industry's position on Internet marketing. The agency has agreed to consider developing rules for online advertising… Read More

The U.S. Food and Drug Administration has questioned the findings of a recently published, long-term Swedish study which found a possible connection between heavy cell phone use and certain forms of brain cancer. In a statement, the FDA said that the findings of the Swedish study are “difficult to interpret” because it used a mailed questionnaire rather than telephone of in-person interviews with subjects, and failed… Read More